|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q39066021
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241121000011.0 |
|
008
|
|
|
241121nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q39066021
|
|
024
|
|
|
‡a
0000-0002-4970-8179
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q39066021
|
|
100
|
0 |
|
‡a
Walter Jäger
‡c
researcher
‡9
en
|
|
375
|
|
|
‡a
1
‡2
iso5218
|
|
400
|
0 |
|
‡a
Walter Jäger
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's 12(S)-HETE increases intracellular Ca(2+) in lymph-endothelial cells disrupting their barrier function in vitro; stabilization by clinical drugs impairing calcium supply
|
|
670
|
|
|
‡a
Author's A eudesmane-type sesquiterpene isolated from Pluchea odorata (L.) Cass. combats three hallmarks of cancer cells: Unrestricted proliferation, escape from apoptosis and early metastatic outgrowth in vitro
|
|
670
|
|
|
‡a
Author's A novel N-hydroxy-N'-aminoguanidine derivative inhibits ribonucleotide reductase activity: Effects in human HL-60 promyelocytic leukemia cells and synergism with arabinofuranosylcytosine
|
|
670
|
|
|
‡a
Author's A novel N-hydroxy-N'-aminoguanidine derivative inhibits ribonucleotide reductase activity: Effects in human HL-60 promyelocytic leukemia cells and synergism with arabinofuranosylcytosine (Ara-C).
|
|
670
|
|
|
‡a
Author's A resveratrol analog termed 3,3',4,4',5,5'-hexahydroxy-trans-stilbene is a potent HIV-1 inhibitor
|
|
670
|
|
|
‡a
Author's AHR/CYP1A1 interplay triggers lymphatic barrier breaching in breast cancer spheroids by inducing 12
|
|
670
|
|
|
‡a
Author's AHR/CYP1A1 interplay triggers lymphatic barrier breaching in breast cancer spheroids by inducing 12(S)-HETE synthesis
|
|
670
|
|
|
‡a
Author's An Exploratory Microdialysis Study to Assess the Ocular Pharmacokinetics of Ciprofloxacin Eye Drops in Rabbits
|
|
670
|
|
|
‡a
Author's Anticancer Properties of Natural Products
|
|
670
|
|
|
‡a
Author's Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells.
|
|
670
|
|
|
‡a
Author's Cefazolin and linezolid penetration into sternal cancellous bone during coronary artery bypass grafting.
|
|
670
|
|
|
‡a
Author's Colon cancer cell-derived 12(S)-HETE induces the retraction of cancer-associated fibroblast via MLC2, RHO/ROCK and Ca2+ signalling
|
|
670
|
|
|
‡a
Author's Combination effects of digalloylresveratrol with arabinofuranosylcytosine and difluorodeoxycytidine in human leukemia and pancreatic cancer cells
|
|
670
|
|
|
‡a
Author's Combined Metabolomic Analysis of Plasma and Urine Reveals AHBA, Tryptophan and Serotonin Metabolism as Potential Risk Factors in Gestational Diabetes Mellitus (GDM).
|
|
670
|
|
|
‡a
Author's Cytochrome P450 3A-mediated metabolism of the topoisomerase I inhibitor 9-aminocamptothecin: impact on cancer therapy
|
|
670
|
|
|
‡a
Author's Digalloylresveratrol, a novel resveratrol analog inhibits the growth of human pancreatic cancer cells.
|
|
670
|
|
|
‡a
Author's Effect of cardiopulmonary bypass on regional antibiotic penetration into lung tissue.
|
|
670
|
|
|
‡a
Author's Effects of Scrophularia extracts on tumor cell proliferation, death and intravasation through lymphoendothelial cell barriers
|
|
670
|
|
|
‡a
Author's Expression of organic anion-transporting polypeptides 1B1 and 1B3 in ovarian cancer cells: relevance for paclitaxel transport
|
|
670
|
|
|
‡a
Author's Expression of sulfotransferases and sulfatases in human breast cancer: impact on resveratrol metabolism
|
|
670
|
|
|
‡a
Author's Fenofibrate inhibits tumour intravasation by several independent mechanisms in a 3-dimensional co-culture model
|
|
670
|
|
|
‡a
Author's Gut and microbial resveratrol metabolite profiling after moderate long-term consumption of red wine versus dealcoholized red wine in humans by an optimized ultra-high-pressure liquid chromatography tandem mass spectrometry method.
|
|
670
|
|
|
‡a
Author's Hepatic Glucuronidation of Resveratrol: Interspecies Comparison of Enzyme Kinetic Profiles in Human, Mouse, Rat, and Dog
|
|
670
|
|
|
‡a
Author's Hepatotoxic seafood poisoning
|
|
670
|
|
|
‡a
Author's Hepatotoxic seafood poisoning (HSP) due to microcystins: a threat from the ocean?
|
|
670
|
|
|
‡a
Author's Hsp90 stabilizes Cdc25A and counteracts heat shock-mediated Cdc25A degradation and cell-cycle attenuation in pancreatic carcinoma cells
|
|
670
|
|
|
‡a
Author's Impact of xanthohumol (a prenylated flavonoid from hops) on DNA stability and other health-related biochemical parameters: Results of human intervention trials
|
|
670
|
|
|
‡a
Author's In vitro characterisation of the anti-intravasative properties of the marine product heteronemin.
|
|
670
|
|
|
‡a
Author's Inhibition of tumour spheroid-induced prometastatic intravasation gates in the lymph endothelial cell barrier by carbamazepine: drug testing in a 3D model
|
|
670
|
|
|
‡a
Author's Interaction of 11C-tariquidar and 11C-elacridar with P-glycoprotein and breast cancer resistance protein at the human blood-brain barrier
|
|
670
|
|
|
‡a
Author's Internal mammary artery harvesting influences antibiotic penetration into presternal tissue
|
|
670
|
|
|
‡a
Author's Intravasation of SW620 colon cancer cell spheroids through the blood endothelial barrier is inhibited by clinical drugs and flavonoids in vitro.
|
|
670
|
|
|
‡a
Author's Lidocaine/tetracaine patch (Rapydan) for topical anaesthesia before arterial access: a double-blind, randomized trial.
|
|
670
|
|
|
‡a
Author's Lobatin B inhibits NPM/ALK and NF-κB attenuating anaplastic-large-cell-lymphomagenesis and lymphendothelial tumour intravasation.
|
|
670
|
|
|
‡a
Author's Multifactorial anticancer effects of digalloyl-resveratrol encompass apoptosis, cell-cycle arrest, and inhibition of lymphendothelial gap formation in vitro
|
|
670
|
|
|
‡a
Author's NSCLC cells adapted to EGFR inhibition accumulate EGFR interacting proteins and down-regulate microRNA related to epithelial-mesenchymal transition
|
|
670
|
|
|
‡a
Author's Organic anion transporting polypeptides
|
|
670
|
|
|
‡a
Author's Organic anion transporting polypeptides (OATPs): regulation of expression and function.
|
|
670
|
|
|
‡a
Author's Pharmacists' participation in research: a case of trying to find the time
|
|
670
|
|
|
‡a
Author's Pharmacokinetics of ganciclovir during continuous venovenous hemodiafiltration in critically ill patients
|
|
670
|
|
|
‡a
Author's Pharmacokinetics of intraperitoneal and intravenous fosfomycin in automated peritoneal dialysis patients without peritonitis
|
|
670
|
|
|
‡a
Author's Pharmacokinetics of single ascending doses of the P-glycoprotein inhibitor tariquidar in healthy subjects
|
|
670
|
|
|
‡a
Author's Polypharmacy, multiple natural health products and hepatotoxicity
|
|
670
|
|
|
‡a
Author's Potent protection of gallic acid against DNA oxidation: Results of human and animal experiments
|
|
670
|
|
|
‡a
Author's Proteome profiling of breast cancer biopsies reveals a wound healing signature of cancer-associated fibroblasts
|
|
670
|
|
|
‡a
Author's Specific expression of OATPs in primary small cell lung cancer
|
|
670
|
|
|
‡a
Author's Specific expression of OATPs in primary small cell lung cancer (SCLC) cells as novel biomarkers for diagnosis and therapy
|
|
670
|
|
|
‡a
Author's Study of natural health product adverse reactions (SONAR): active surveillance of adverse events following concurrent natural health product and prescription drug use in community pharmacies
|
|
670
|
|
|
‡a
Author's The germacranolide sesquiterpene lactone neurolenin B of the medicinal plant Neurolaena lobata (L.) R.Br. ex Cass inhibits NPM/ALK-driven cell expansion and NF-κB-driven tumour intravasation
|
|
670
|
|
|
‡a
Author's The Impacts of Genistein and Daidzein on Estrogen Conjugations in Human Breast Cancer Cells: A Targeted Metabolomics Approach
|
|
670
|
|
|
‡a
Author's The sulfatase pathway for estrogen formation: targets for the treatment and diagnosis of hormone-associated tumors
|
|
670
|
|
|
‡a
Author's Tumor-specific expression of organic anion-transporting polypeptides: transporters as novel targets for cancer therapy.
|
|
670
|
|
|
‡a
Author's Xanthohumol attenuates tumour cell-mediated breaching of the lymphendothelial barrier and prevents intravasation and metastasis
|
|
670
|
|
|
‡a
Author's Xanthohumol Prevents DNA Damage by Dietary Carcinogens: Results of a Human Intervention Trial.
|
|
909
|
|
|
‡a
(orcid) 0000000249708179
‡9
1
|
|
919
|
|
|
‡a
combinedmetabolomicanalysisofplasmaandurinerevealsahbatryptophanandserotoninmetabolismaspotentialriskfactorsingestationaldiabetesmellitusgdm
‡A
Combined Metabolomic Analysis of Plasma and Urine Reveals AHBA, Tryptophan and Serotonin Metabolism as Potential Risk Factors in Gestational Diabetes Mellitus (GDM).
‡9
1
|
|
919
|
|
|
‡a
coloncancercellderived12sheteinducestheretractionofcancerassociatedfibroblastviamlc2rhorockandca2+signalling
‡A
Colon cancer cell-derived 12(S)-HETE induces the retraction of cancer-associated fibroblast via MLC2, RHO/ROCK and Ca2+ signalling
‡9
1
|
|
919
|
|
|
‡a
cefazolinandlinezolidpenetrationintosternalcancellousboneduringcoronaryarterybypassgrafting
‡A
Cefazolin and linezolid penetration into sternal cancellous bone during coronary artery bypass grafting.
‡9
1
|
|
919
|
|
|
‡a
antitumoreffectsofkitcanewresveratrolderivativeinaspc1andbxpc3humanpancreaticcarcinomacells
‡A
Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells.
‡9
1
|
|
919
|
|
|
‡a
anticancerpropertiesofnaturalproducts
‡A
Anticancer Properties of Natural Products
‡9
1
|
|
919
|
|
|
‡a
exploratorymicrodialysisstudytoassesstheocularpharmacokineticsofciprofloxacineyedropsinrabbits
‡A
An Exploratory Microdialysis Study to Assess the Ocular Pharmacokinetics of Ciprofloxacin Eye Drops in Rabbits
‡9
1
|
|
919
|
|
|
‡a
ahrcyp1a1interplaytriggerslymphaticbarrierbreachinginbreastcancerspheroidsbyinducing12shetesynthesis
‡A
AHR/CYP1A1 interplay triggers lymphatic barrier breaching in breast cancer spheroids by inducing 12(S)-HETE synthesis
‡9
1
|
|
919
|
|
|
‡a
novelnhydroxynaminoguanidinederivativeinhibitsribonucleotidereductaseactivityeffectsinhumanhl60promyelocyticleukemiacellsandsynergismwitharabinofuranosylcytosine
‡A
A novel N-hydroxy-N'-aminoguanidine derivative inhibits ribonucleotide reductase activity: Effects in human HL-60 promyelocytic leukemia cells and synergism with arabinofuranosylcytosine
‡9
1
|
|
919
|
|
|
‡a
ahrcyp1a1interplaytriggerslymphaticbarrierbreachinginbreastcancerspheroidsbyinducing12
‡A
AHR/CYP1A1 interplay triggers lymphatic barrier breaching in breast cancer spheroids by inducing 12
‡9
1
|
|
919
|
|
|
‡a
eudesmanetypesesquiterpeneisolatedfromplucheaodorata50casscombats3hallmarksofcancercellsunrestrictedproliferationescapefromapoptosisandearlymetastaticoutgrowthinvitro
‡A
A eudesmane-type sesquiterpene isolated from Pluchea odorata (L.) Cass. combats three hallmarks of cancer cells: Unrestricted proliferation, escape from apoptosis and early metastatic outgrowth in vitro
‡9
1
|
|
919
|
|
|
‡a
resveratrolanalogtermed334455hexahydroxytransstilbeneisapotenthiv1inhibitor
‡A
A resveratrol analog termed 3,3',4,4',5,5'-hexahydroxy-trans-stilbene is a potent HIV-1 inhibitor
‡9
1
|
|
919
|
|
|
‡a
12sheteincreasesintracellularca2+inlymphendothelialcellsdisruptingtheirbarrierfunctioninvitrostabilizationbyclinicaldrugsimpairingcalciumsupply
‡A
12(S)-HETE increases intracellular Ca(2+) in lymph-endothelial cells disrupting their barrier function in vitro; stabilization by clinical drugs impairing calcium supply
‡9
1
|
|
919
|
|
|
‡a
novelnhydroxynaminoguanidinederivativeinhibitsribonucleotidereductaseactivityeffectsinhumanhl60promyelocyticleukemiacellsandsynergismwitharabinofuranosylcytosineara100
‡A
A novel N-hydroxy-N'-aminoguanidine derivative inhibits ribonucleotide reductase activity: Effects in human HL-60 promyelocytic leukemia cells and synergism with arabinofuranosylcytosine (Ara-C).
‡9
1
|
|
919
|
|
|
‡a
effectsofscrophulariaextractsontumorcellproliferationdeathandintravasationthroughlymphoendothelialcellbarriers
‡A
Effects of Scrophularia extracts on tumor cell proliferation, death and intravasation through lymphoendothelial cell barriers
‡9
1
|
|
919
|
|
|
‡a
organicaniontransportingpolypeptides
‡A
Organic anion transporting polypeptides
‡9
1
|
|
919
|
|
|
‡a
organicaniontransportingpolypeptidesoatpsregulationofexpressionandfunction
‡A
Organic anion transporting polypeptides (OATPs): regulation of expression and function.
‡9
1
|
|
919
|
|
|
‡a
pharmacistsparticipationinresearchacaseoftryingtofindthetime
‡A
Pharmacists' participation in research: a case of trying to find the time
‡9
1
|
|
919
|
|
|
‡a
pharmacokineticsofganciclovirduringcontinuousvenovenoushemodiafiltrationincriticallyillpatients
‡A
Pharmacokinetics of ganciclovir during continuous venovenous hemodiafiltration in critically ill patients
‡9
1
|
|
919
|
|
|
‡a
pharmacokineticsofintraperitonealandintravenousfosfomycininautomatedperitonealdialysispatientswithoutperitonitis
‡A
Pharmacokinetics of intraperitoneal and intravenous fosfomycin in automated peritoneal dialysis patients without peritonitis
‡9
1
|
|
919
|
|
|
‡a
pharmacokineticsofsingleascendingdosesofthepglycoproteininhibitortariquidarinhealthysubjects
‡A
Pharmacokinetics of single ascending doses of the P-glycoprotein inhibitor tariquidar in healthy subjects
‡9
1
|
|
919
|
|
|
‡a
polypharmacymultiplenaturalhealthproductsandhepatotoxicity
‡A
Polypharmacy, multiple natural health products and hepatotoxicity
‡9
1
|
|
919
|
|
|
‡a
potentprotectionofgallicacidagainstdnaoxidationresultsofhumanandanimalexperiments
‡A
Potent protection of gallic acid against DNA oxidation: Results of human and animal experiments
‡9
1
|
|
919
|
|
|
‡a
proteomeprofilingofbreastcancerbiopsiesrevealsawoundhealingsignatureofcancerassociatedfibroblasts
‡A
Proteome profiling of breast cancer biopsies reveals a wound healing signature of cancer-associated fibroblasts
‡9
1
|
|
919
|
|
|
‡a
specificexpressionofoatpsinprimarysmallcelllungcancer
‡A
Specific expression of OATPs in primary small cell lung cancer
‡9
1
|
|
919
|
|
|
‡a
nsclccellsadaptedtoegfrinhibitionaccumulateegfrinteractingproteinsanddownregulatemicrornarelatedtoepithelialmesenchymaltransition
‡A
NSCLC cells adapted to EGFR inhibition accumulate EGFR interacting proteins and down-regulate microRNA related to epithelial-mesenchymal transition
‡9
1
|
|
919
|
|
|
‡a
multifactorialanticancereffectsofdigalloylresveratrolencompassapoptosiscellcyclearrestandinhibitionoflymphendothelialgapformationinvitro
‡A
Multifactorial anticancer effects of digalloyl-resveratrol encompass apoptosis, cell-cycle arrest, and inhibition of lymphendothelial gap formation in vitro
‡9
1
|
|
919
|
|
|
‡a
specificexpressionofoatpsinprimarysmallcelllungcancersclccellsasnovelbiomarkersfordiagnosisandtherapy
‡A
Specific expression of OATPs in primary small cell lung cancer (SCLC) cells as novel biomarkers for diagnosis and therapy
‡9
1
|
|
919
|
|
|
‡a
studyofnaturalhealthproductadversereactionssonaractivesurveillanceofadverseeventsfollowingconcurrentnaturalhealthproductandprescriptiondruguseincommunitypharmacies
‡A
Study of natural health product adverse reactions (SONAR): active surveillance of adverse events following concurrent natural health product and prescription drug use in community pharmacies
‡9
1
|
|
919
|
|
|
‡a
germacranolidesesquiterpenelactoneneuroleninbofthemedicinalplantneurolaenalobata50rbrexcassinhibitsnpmalkdrivencellexpansionandnfκbdriventumourintravasation
‡A
The germacranolide sesquiterpene lactone neurolenin B of the medicinal plant Neurolaena lobata (L.) R.Br. ex Cass inhibits NPM/ALK-driven cell expansion and NF-κB-driven tumour intravasation
‡9
1
|
|
919
|
|
|
‡a
impactsofgenisteinanddaidzeinonestrogenconjugationsinhumanbreastcancercellsatargetedmetabolomicsapproach
‡A
The Impacts of Genistein and Daidzein on Estrogen Conjugations in Human Breast Cancer Cells: A Targeted Metabolomics Approach
‡9
1
|
|
919
|
|
|
‡a
sulfatasepathwayforestrogenformationtargetsforthetreatmentanddiagnosisofhormoneassociatedtumors
‡A
The sulfatase pathway for estrogen formation: targets for the treatment and diagnosis of hormone-associated tumors
‡9
1
|
|
919
|
|
|
‡a
tumorspecificexpressionoforganicaniontransportingpolypeptidestransportersasnoveltargetsforcancertherapy
‡A
Tumor-specific expression of organic anion-transporting polypeptides: transporters as novel targets for cancer therapy.
‡9
1
|
|
919
|
|
|
‡a
xanthohumolattenuatestumourcellmediatedbreachingofthelymphendothelialbarrierandpreventsintravasationandmetastasis
‡A
Xanthohumol attenuates tumour cell-mediated breaching of the lymphendothelial barrier and prevents intravasation and metastasis
‡9
1
|
|
919
|
|
|
‡a
xanthohumolpreventsdnadamagebydietarycarcinogensresultsofahumaninterventiontrial
‡A
Xanthohumol Prevents DNA Damage by Dietary Carcinogens: Results of a Human Intervention Trial.
‡9
1
|
|
919
|
|
|
‡a
lobatinbinhibitsnpmalkandnfκbattenuatinganaplasticlargecelllymphomagenesisandlymphendothelialtumourintravasation
‡A
Lobatin B inhibits NPM/ALK and NF-κB attenuating anaplastic-large-cell-lymphomagenesis and lymphendothelial tumour intravasation.
‡9
1
|
|
919
|
|
|
‡a
lidocainetetracainepatchrapydanfortopicalanaesthesiabeforearterialaccessadoubleblindrandomizedtrial
‡A
Lidocaine/tetracaine patch (Rapydan) for topical anaesthesia before arterial access: a double-blind, randomized trial.
‡9
1
|
|
919
|
|
|
‡a
intravasationofsw620coloncancercellspheroidsthroughthebloodendothelialbarrierisinhibitedbyclinicaldrugsandflavonoidsinvitro
‡A
Intravasation of SW620 colon cancer cell spheroids through the blood endothelial barrier is inhibited by clinical drugs and flavonoids in vitro.
‡9
1
|
|
919
|
|
|
‡a
internalmammaryarteryharvestinginfluencesantibioticpenetrationintopresternaltissue
‡A
Internal mammary artery harvesting influences antibiotic penetration into presternal tissue
‡9
1
|
|
919
|
|
|
‡a
interactionof11ctariquidarand11celacridarwithpglycoproteinandbreastcancerresistanceproteinatthehumanbloodbrainbarrier
‡A
Interaction of 11C-tariquidar and 11C-elacridar with P-glycoprotein and breast cancer resistance protein at the human blood-brain barrier
‡9
1
|
|
919
|
|
|
‡a
inhibitionoftumourspheroidinducedprometastaticintravasationgatesinthelymphendothelialcellbarrierbycarbamazepinedrugtestingina3dmodel
‡A
Inhibition of tumour spheroid-induced prometastatic intravasation gates in the lymph endothelial cell barrier by carbamazepine: drug testing in a 3D model
‡9
1
|
|
919
|
|
|
‡a
combinationeffectsofdigalloylresveratrolwitharabinofuranosylcytosineanddifluorodeoxycytidineinhumanleukemiaandpancreaticcancercells
‡A
Combination effects of digalloylresveratrol with arabinofuranosylcytosine and difluorodeoxycytidine in human leukemia and pancreatic cancer cells
‡9
1
|
|
919
|
|
|
‡a
invitrocharacterisationoftheantiintravasativepropertiesofthemarineproductheteronemin
‡A
In vitro characterisation of the anti-intravasative properties of the marine product heteronemin.
‡9
1
|
|
919
|
|
|
‡a
impactofxanthohumolaprenylatedflavonoidfromhopsondnastabilityandotherhealthrelatedbiochemicalparametersresultsofhumaninterventiontrials
‡A
Impact of xanthohumol (a prenylated flavonoid from hops) on DNA stability and other health-related biochemical parameters: Results of human intervention trials
‡9
1
|
|
919
|
|
|
‡a
hsp90stabilizescdc25aandcounteractsheatshockmediatedcdc25adegradationandcellcycleattenuationinpancreaticcarcinomacells
‡A
Hsp90 stabilizes Cdc25A and counteracts heat shock-mediated Cdc25A degradation and cell-cycle attenuation in pancreatic carcinoma cells
‡9
1
|
|
919
|
|
|
‡a
hepatotoxicseafoodpoisoninghspduetomicrocystinsathreatfromtheocean
‡A
Hepatotoxic seafood poisoning (HSP) due to microcystins: a threat from the ocean?
‡9
1
|
|
919
|
|
|
‡a
hepatotoxicseafoodpoisoning
‡A
Hepatotoxic seafood poisoning
‡9
1
|
|
919
|
|
|
‡a
hepaticglucuronidationofresveratrolinterspeciescomparisonofenzymekineticprofilesinhumanmouseratanddog
‡A
Hepatic Glucuronidation of Resveratrol: Interspecies Comparison of Enzyme Kinetic Profiles in Human, Mouse, Rat, and Dog
‡9
1
|
|
919
|
|
|
‡a
gutandmicrobialresveratrolmetaboliteprofilingaftermoderatelongtermconsumptionofredwineversusdealcoholizedredwineinhumansbyanoptimizedultrahighpressureliquidchromatographytandemmassspectrometrymethod
‡A
Gut and microbial resveratrol metabolite profiling after moderate long-term consumption of red wine versus dealcoholized red wine in humans by an optimized ultra-high-pressure liquid chromatography tandem mass spectrometry method.
‡9
1
|
|
919
|
|
|
‡a
fenofibrateinhibitstumourintravasationbyseveralindependentmechanismsina3dimensionalcoculturemodel
‡A
Fenofibrate inhibits tumour intravasation by several independent mechanisms in a 3-dimensional co-culture model
‡9
1
|
|
919
|
|
|
‡a
expressionofsulfotransferasesandsulfatasesinhumanbreastcancerimpactonresveratrolmetabolism
‡A
Expression of sulfotransferases and sulfatases in human breast cancer: impact on resveratrol metabolism
‡9
1
|
|
919
|
|
|
‡a
expressionoforganicaniontransportingpolypeptides1b1and1b3inovariancancercellsrelevanceforpaclitaxeltransport
‡A
Expression of organic anion-transporting polypeptides 1B1 and 1B3 in ovarian cancer cells: relevance for paclitaxel transport
‡9
1
|
|
919
|
|
|
‡a
effectofcardiopulmonarybypassonregionalantibioticpenetrationintolungtissue
‡A
Effect of cardiopulmonary bypass on regional antibiotic penetration into lung tissue.
‡9
1
|
|
919
|
|
|
‡a
digalloylresveratrolanovelresveratrolanaloginhibitsthegrowthofhumanpancreaticcancercells
‡A
Digalloylresveratrol, a novel resveratrol analog inhibits the growth of human pancreatic cancer cells.
‡9
1
|
|
919
|
|
|
‡a
cytochromep4503amediatedmetabolismofthetopoisomerase1inhibitor9aminocamptothecinimpactoncancertherapy
‡A
Cytochrome P450 3A-mediated metabolism of the topoisomerase I inhibitor 9-aminocamptothecin: impact on cancer therapy
‡9
1
|
|
946
|
|
|
‡a
b
‡9
1
|
|
996
|
|
|
‡2
DNB|134624343
|
|
996
|
|
|
‡2
LC|n 88633462
|
|
996
|
|
|
‡2
ISNI|000000003071200X
|
|
996
|
|
|
‡2
NTA|068935544
|
|
996
|
|
|
‡2
DNB|1077382081
|
|
996
|
|
|
‡2
ISNI|0000000117889721
|
|
996
|
|
|
‡2
NTA|073513113
|
|
996
|
|
|
‡2
ISNI|0000000397177410
|
|
996
|
|
|
‡2
NTA|137035640
|
|
996
|
|
|
‡2
BIBSYS|90161357
|
|
996
|
|
|
‡2
NTA|314558284
|
|
996
|
|
|
‡2
ISNI|0000000388412183
|
|
996
|
|
|
‡2
LIH|LNB:V-327691;=BO
|
|
996
|
|
|
‡2
ISNI|0000000075303568
|
|
996
|
|
|
‡2
ISNI|0000000390225651
|
|
996
|
|
|
‡2
NTA|070094497
|
|
996
|
|
|
‡2
LNB|LNC10-000087363
|
|
996
|
|
|
‡2
ISNI|0000000391589473
|
|
996
|
|
|
‡2
DNB|1015506534
|
|
996
|
|
|
‡2
NTA|18905087X
|
|
996
|
|
|
‡2
NUKAT|n 2006136185
|
|
996
|
|
|
‡2
DNB|1050883586
|
|
996
|
|
|
‡2
DNB|1201361478
|
|
996
|
|
|
‡2
BIBSYS|14022550
|
|
996
|
|
|
‡2
NTA|241462851
|
|
996
|
|
|
‡2
NTA|315073462
|
|
996
|
|
|
‡2
PLWABN|9810560480605606
|
|
996
|
|
|
‡2
ISNI|0000000388459803
|
|
996
|
|
|
‡2
DNB|1012275736
|
|
996
|
|
|
‡2
RERO|A013676360
|
|
996
|
|
|
‡2
LC|no2023060569
|
|
996
|
|
|
‡2
BIBSYS|90109586
|
|
996
|
|
|
‡2
NTA|17442504X
|
|
996
|
|
|
‡2
BIBSYS|1542227329192
|
|
996
|
|
|
‡2
DNB|1048340848
|
|
996
|
|
|
‡2
NTA|188839704
|
|
996
|
|
|
‡2
NTA|433973897
|
|
996
|
|
|
‡2
NTA|070020140
|
|
996
|
|
|
‡2
ISNI|0000000389658054
|
|
996
|
|
|
‡2
ISNI|0000000396330532
|
|
996
|
|
|
‡2
CAOONL|ncf10239938
|
|
996
|
|
|
‡2
LC|n 87846152
|
|
996
|
|
|
‡2
DNB|1050479890
|
|
996
|
|
|
‡2
PLWABN|9810558116105606
|
|
996
|
|
|
‡2
ISNI|0000000040245513
|
|
996
|
|
|
‡2
DNB|1080250107
|
|
996
|
|
|
‡2
J9U|987007418985405171
|
|
996
|
|
|
‡2
NTA|069911592
|
|
996
|
|
|
‡2
SZ|1048340848
|
|
996
|
|
|
‡2
ISNI|0000000389704209
|
|
996
|
|
|
‡2
PLWABN|9810539167205606
|
|
996
|
|
|
‡2
NTA|305416685
|
|
996
|
|
|
‡2
ISNI|0000000392770864
|
|
996
|
|
|
‡2
BIBSYS|90613184
|
|
996
|
|
|
‡2
DNB|1248072987
|
|
996
|
|
|
‡2
SUDOC|250029804
|
|
996
|
|
|
‡2
ISNI|0000000050651603
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
